SLC7A11 and inflammatory bowel disease: Sulfasalazine (SSZ), an FDA-approved drug for the treatment of rheumatoid arthritis and inflammatory bowel diseases (IBD), is a potent xCT inhibitor and has attracted a lot of interest to be repurposed as an anticancer drug.